Neuromod Pros/Cons

























St. Jude Medical sales of neuromodulation products were $140 million in the second quarter of 2016, a 19 percent increase on a reported basis and a 20 percent increase on a constant currency basis compared to the prior year quarter. Neuromodulation growth was driven by the St. Jude Medical Burst technology offering in international markets, U.S. launch of the Axium™ system as well as the introduction of the Infinity™ DBS system and directional lead in Europe.

Ssssshhhh.....